European Society of Cardiology (ESC)

news

Jardiance^® displays 21 percent risk reduction in heart failure patients

31 August 2021 | By Anna Begley (European Pharmaceutical Review)

Jardiance displayed a 21 percent risk reduction in adults with heart failure with preserved ejection fraction in Phase III study.

article

Beyond nutrition: vitamins and n-3 polyunsaturated fatty acids as APIs

18 November 2019 | By Eric Ciappio (DSM)

Active pharmaceutical ingredients (APIs) are important compounds used in the manufacture of pharmaceutical drug products. Eric Ciappio discusses the potential of vitamins and n-3 polyunsaturated fatty acids (PUFAs) as APIs, with a focus on their clinical relevance.

news

TECOS analysis adds heart failure data for sitagliptin

2 September 2015 | By Victoria White

New TECOS study findings have shown that patients with type-2 diabetes can safely take sitagliptin without an increased risk of cardiovascular complications...